Bretylium Tosylate In Dextrose 5%
Bretylium Tosylate In Dextrose 5% Brand names, Bretylium Tosylate In Dextrose 5% Analogs
Bretylium Tosylate In Dextrose 5% Brand Names Mixture
- No information avaliable
Bretylium Tosylate In Dextrose 5% Chemical_Formula
C11H17BrN+
Bretylium Tosylate In Dextrose 5% RX_link
http://www.rxlist.com/cgi/generic3/bretosy.htm
Bretylium Tosylate In Dextrose 5% fda sheet
Bretylium Tosylate In Dextrose 5% msds (material safety sheet)
Bretylium Tosylate In Dextrose 5% Synthesis Reference
No information avaliable
Bretylium Tosylate In Dextrose 5% Molecular Weight
243.163 g/mol
Bretylium Tosylate In Dextrose 5% Melting Point
No information avaliable
Bretylium Tosylate In Dextrose 5% H2O Solubility
Freely soluble
Bretylium Tosylate In Dextrose 5% State
Solid
Bretylium Tosylate In Dextrose 5% LogP
No information avaliable
Bretylium Tosylate In Dextrose 5% Dosage Forms
Solution for injection (50mg/mL)
Bretylium Tosylate In Dextrose 5% Indication
For use in the prophylaxis and therapy of ventricular fibrillation. Also used in the treatment of life-threatening ventricular arrhythmias, such as ventricular tachycardia, that have failed to respond to adequate doses of a first-line antiarrhythmic agent, such as lidocaine.
Bretylium Tosylate In Dextrose 5% Pharmacology
Bretylium is a bromobenzyl quaternary ammonium compound which selectively accumulates in sympathetic ganglia and their postganglionic adrenergic neurons where it inhibits norepinephrine release by depressing adrenergic nerve terminal excitability. Bretylium also suppresses ventricular fibrillation and ventricular arrhythmias.
Bretylium Tosylate In Dextrose 5% Absorption
No information avaliable
Bretylium Tosylate In Dextrose 5% side effects and Toxicity
Oral, mouse: LD50 = 400 mg/kg. In the presence of life-threatening arrhythmias, underdosing with bretylium probably presents a greater risk to the patient than potential overdosage. However, one case of accidental overdose has been reported in which a rapidly injected intravenous bolus of 30 mg/kg was given instead of an intended 10 mg/kg dose during an episode of ventricular tachycardia. Marked hypertension resulted, followed by protracted refractory hypotension. The patient expired 18 hours later in asystole, complicated by renal failure and aspiration pneumonitis. Bretylium serum levels were 8000 ng/mL.
Bretylium Tosylate In Dextrose 5% Patient Information
Bretylium Tosylate In Dextrose 5% Organisms Affected
Humans and other mammals
